Samrat Pharmachem Limited

BSE:530125 Stock Report

Market Cap: ₹1.2b

Samrat Pharmachem Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Lalit Mehta

Chief executive officer

₹4.8m

Total compensation

CEO salary percentage100.0%
CEO tenure32.5yrs
CEO ownership14.0%
Management average tenureno data
Board average tenure9.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Lalit Mehta's remuneration changed compared to Samrat Pharmachem's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹65m

Jun 30 2024n/an/a

₹36m

Mar 31 2024₹5m₹5m

₹22m

Dec 31 2023n/an/a

₹225k

Sep 30 2023n/an/a

₹18m

Jun 30 2023n/an/a

₹79m

Mar 31 2023₹4m₹4m

₹166m

Dec 31 2022n/an/a

₹244m

Sep 30 2022n/an/a

₹287m

Jun 30 2022n/an/a

₹256m

Mar 31 2022₹4m₹4m

₹172m

Dec 31 2021n/an/a

₹117m

Sep 30 2021n/an/a

₹68m

Jun 30 2021n/an/a

₹55m

Mar 31 2021₹2m₹2m

₹53m

Dec 31 2020n/an/a

₹42m

Sep 30 2020n/an/a

₹31m

Jun 30 2020n/an/a

₹32m

Mar 31 2020₹2m₹2m

₹42m

Dec 31 2019n/an/a

₹51m

Sep 30 2019n/an/a

₹50m

Jun 30 2019n/an/a

₹34m

Mar 31 2019₹2m₹2m

₹15m

Dec 31 2018n/an/a

₹9m

Sep 30 2018n/an/a

₹21m

Jun 30 2018n/an/a

₹27m

Mar 31 2018₹2m₹2m

₹32m

Compensation vs Market: Lalit's total compensation ($USD56.14K) is above average for companies of similar size in the Indian market ($USD42.22K).

Compensation vs Earnings: Lalit's compensation has increased by more than 20% in the past year.

CEO

Lalit Mehta (88 yo)

32.5yrs

Tenure

₹4,800,000

Compensation

Mr. Lalit Damodar Mehta serves as the Chairman, Chief Executive Officer and Managing Director at Samrat Pharmachem Limited and has been its Non-Independent Executive Director since June 16, 1992. Mr. Mehta...

Board Members

NamePositionTenureCompensationOwnership
Lalit Mehta
Founder32.5yrs₹4.80m13.97%
₹ 166.3m
Rajesh Mehta
CFO & Non-Independent Executive Director32.5yrs₹4.20m12.41%
₹ 147.8m
Megh Mehta
Non-Independent Executive Director9.2yrs₹2.10m1.71%
₹ 20.4m
Renu Dharod
Non-Executive Independent Director9.8yrs₹200.00k0.00081%
₹ 9.6k
Manishkumar Pipalia
Non-Executive Independent Directorless than a yearno datano data
Sachin Kothary
Non-Executive Independent Directorless than a yearno datano data
Megha Jain
Non-Executive Independent Directorless than a yearno datano data

9.2yrs

Average Tenure

55yo

Average Age

Experienced Board: 530125's board of directors are considered experienced (9.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 20:08
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Samrat Pharmachem Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution